Diagnostic evaluation of neurologic metastasesJEYAPALAN, Suriya A; BATCHELOR, Tracy T.Cancer investigation. 2000, Vol 18, Num 4, pp 381-394, issn 0735-7907Article

Primary Central Nervous System LymphomaGERSTNER, Elizabeth R; BATCHELOR, Tracy T.Archives of neurology (Chicago). 2010, Vol 67, Num 3, pp 291-297, issn 0003-9942, 7 p.Article

Vascular endothelial growth factor inhibitors in malignant gliomasBRASTIANOS, Priscilla K; BATCHELOR, Tracy T.Targeted oncology. 2010, Vol 5, Num 3, pp 167-174, issn 1776-2596, 8 p.Article

A Man with Visual-Field Loss and a Mass in the BrainBATCHELOR, Tracy T; GREGORY SORENSEN, A; LOUIS, David N et al.The New England journal of medicine. 2012, Vol 366, Num 22, pp 2112-2120, issn 0028-4793, 9 p.Article

Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphomaGERBER, David E; GROSSMAN, Stuart A; BATCHELOR, Tracy et al.Cancer chemotherapy and pharmacology. 2007, Vol 59, Num 6, pp 817-823, issn 0344-5704, 7 p.Article

A woman with difficulty walking, headache, and nauseaBATCHELOR, Tracy T; BUCHBINDER, Bradley R; HARRIS, Nancy Lee et al.The New England journal of medicine. 2005, Vol 352, Num 2, pp 185-194, issn 0028-4793, 10 p.Article

Malignant peripheral nerve sheath tumor: The clinical spectrum and outcome of treatmentBAEHRING, Joachim M; BETENSKY, Rebecca A; BATCHELOR, Tracy T et al.Neurology. 2003, Vol 61, Num 5, pp 696-698, issn 0028-3878, 3 p.Article

A Safety Run-In and Randomized Phase 2 Study of Cilengitide Combined With Chemoradiation for Newly Diagnosed Glioblastoma (NABTT 0306)NABORS, L. Burt; MIKKELSEN, Thomas; FISHER, Joy D et al.Cancer. 2012, Vol 118, Num 22, pp 5601-5607, issn 0008-543X, 7 p.Article

Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II TrialGROSSMAN, Stuart A; XIAOBU YE; CHAMBERLAIN, Marc et al.Journal of clinical oncology. 2009, Vol 27, Num 25, pp 4155-4161, issn 0732-183X, 7 p.Article

Primary CNS lymphomaBATCHELOR, Tracy; LOEFFLER, Jay S.Journal of clinical oncology. 2006, Vol 24, Num 8, pp 1281-1288, issn 0732-183X, 8 p.Article

Clinical features and diagnosis of primary central nervous system lymphomaFITZSIMMONS, April; UPCHURCH, Kristen; BATCHELOR, Tracy et al.Hematology/oncology clinics of North America. 2005, Vol 19, Num 4, issn 0889-8588, vii, 689-703 [16 p.]Article

Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: A report of NABTT 96-07BATCHELOR, Tracy; CARSON, Kathryn; O'NEILL, Alison et al.Journal of clinical oncology. 2003, Vol 21, Num 6, pp 1044-1049, issn 0732-183X, 6 p.Article

LONG-TERM OUTCOMES OF PATIENTS WITH SPINAL CORD GLIOMAS TREATED BY MODERN CONFORMAL RADIATION TECHNIQUESKAHN, Jenna; LOEFFLER, Jay Steven; NIEMIERKO, Andrzej et al.International journal of radiation oncology, biology, physics. 2011, Vol 81, Num 1, pp 232-238, issn 0360-3016, 7 p.Article

Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma : an International Primary CNS Lymphoma Collaborative Group reportDOOLITTLE, Nancy D; ABREY, Lauren E; SCHIFF, David et al.Blood. 2008, Vol 111, Num 3, pp 1085-1093, issn 0006-4971, 9 p.Article

Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomasFINE, Howard A; WEN, Patrick Y; MAHER, Elizabeth A et al.Journal of clinical oncology. 2003, Vol 21, Num 12, pp 2299-2304, issn 0732-183X, 6 p.Article

An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitisJAECKLE, Kurt A; BATCHELOR, Tracy; ROGERS, Lisa et al.Journal of neuro-oncology. 2002, Vol 57, Num 3, pp 231-239, issn 0167-594XArticle

LONG-TERM OUTCOME IN PCNSL PATIENTS TREATED WITH HIGH-DOSE METHOTREXATE AND DEFERRED RADIATIONGERSTNER, Elizabeth R; CARSON, Kathryn A; GROSSMAN, Stuart A et al.Neurology. 2008, Vol 70, Num 5, pp 401-402, issn 0028-3878, 2 p.Article

Leptomeningeal metastasesKESARI, Santosh; BATCHELOR, Tracy T.Neurologic clinics. 2003, Vol 21, Num 1, issn 0733-8619, vii, 25-66 [43 p.]Article

Prospective study of meat intake and dietary nitrates, nitrites, and nitrosamines and risk of adult gliomaMICHAUD, Dominique S; HOLICK, Crystal N; BATCHELOR, Tracy T et al.The American journal of clinical nutrition. 2009, Vol 90, Num 3, pp 570-577, issn 0002-9165, 8 p.Article

Angiogenesis in brain tumoursJOIN, Rakesh K; DI TOMASO, Emmanuelle; DUDA, Dan C et al.Nature reviews. Neuroscience (Print). 2007, Vol 8, Num 8, pp 610-622, issn 1471-003X, 13 p.Article

Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas : Correlation with EGFR status, tumor grade, and survivalMIZOGUCHI, Masahiro; BETENSKY, Rebecca A; BATCHELOR, Tracy T et al.Journal of neuropathology and experimental neurology. 2006, Vol 65, Num 12, pp 1181-1188, issn 0022-3069, 8 p.Article

Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastomaAGHI, Manish; GAVIANI, Paola; HENSON, John W et al.Clinical cancer research. 2005, Vol 11, Num 24, pp 8600-8605, issn 1078-0432, 6 p., 1Article

Bayesian Adaptive Randomized Trial Design for Patients With Recurrent GlioblastomaTRIPPA, Lorenzo; LEE, Eudocia Q; WEN, Patrick Y et al.Journal of clinical oncology. 2012, Vol 30, Num 26, pp 3258-3263, issn 0732-183X, 6 p.Article

YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomasNUTT, Catherine L; BETENSKY, Rebecca A; BROWER, Melissa A et al.Clinical cancer research. 2005, Vol 11, Num 6, pp 2258-2264, issn 1078-0432, 7 p.Article

T₁- and T^*₂-dominant extravasation correction in DSC-MRI: Part II—predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patientsEMBLEM, Kyrre E; BJORNERUD, Atle; MOURIDSEN, Kim et al.Journal of cerebral blood flow and metabolism. 2011, Vol 31, Num 10, pp 2054-2064, issn 0271-678X, 11 p.Article